Fibromuscular Dysplasia (FMD): Causes, Symptoms, Diagnosis & Treatment

Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory vascular disease causing abnormal cell growth in medium-sized artery walls. This creates a "string of beads" appearance—alternating narrowing (stenosis) and dilation (aneurysm). It most commonly affects the renal arteries (causing hypertension) and carotid/vertebral arteries (causing neurologic symptoms), but can involve almost any arterial bed.

Who Is Affected?

FMD predominantly affects women (9:1 female-to-male ratio), typically diagnosed between ages 30-50. However, it can occur at any age, including children.

Causes & Risk Factors

The exact etiology is unknown, but contributing factors include:

  • Genetics: Familial clustering suggests genetic susceptibility; several loci identified.
  • Hormonal influence: Female predominance and onset often during reproductive years implicate estrogen.
  • Mechanical stress: Arterial wall stress from blood flow may trigger abnormal remodeling.
  • Associated conditions: Ehlers-Danlos syndrome, Alport syndrome, neurofibromatosis type 1.
  • Smoking: Strongly associated with more severe disease and aneurysms.

Symptoms (Vary by Arterial Bed)

  • Renal arteries: Resistant hypertension (often in young women), flank bruit, renal atrophy.
  • Carotid/vertebral arteries: Headache (often pulsatile), pulsatile tinnitus, neck pain, dizziness, transient ischemic attacks (TIAs), stroke, Horner's syndrome.
  • Mesenteric arteries: Postprandial abdominal pain, weight loss, food fear.
  • Peripheral arteries: Limb claudication, cold extremities.
  • Coronary arteries: Angina, myocardial infarction, SCAD (spontaneous coronary artery dissection) association.

Diagnosis

  • Imaging: CT angiography (CTA) or MR angiography (MRA) are first-line. Catheter angiography remains gold standard for detail.
  • Ultrasound: Duplex ultrasound for renal/carotid screening and follow-up.
  • Screening: Once diagnosed, image all accessible arterial beds (renal, carotid, vertebral, mesenteric, iliac) due to multifocal nature.

Treatment

Medical Management

  • Antiplatelet therapy (aspirin) for cerebrovascular FMD.
  • Antihypertensives (ACE inhibitors/ARBs preferred for renal FMD).
  • Statins for cardiovascular risk reduction (though not for FMD itself).
  • Smoking cessation is critical.

Revascularization

  • Balloon angioplasty (PTA): First-line for symptomatic renal artery stenosis (cures/improves hypertension in ~70-80%). Stents rarely needed unless dissection.
  • Stenting/surgery: For aneurysms, dissections, or failed PTA.
  • Carotid revascularization for recurrent TIAs/stroke despite medical therapy.

Prognosis & Follow-Up

Most patients live normal lifespans with proper management. Lifelong vascular surveillance (imaging every 1-3 years) is recommended to monitor for new lesions, aneurysm growth, or dissections. Multidisciplinary care (vascular medicine, nephrology, neurology, genetics) optimizes outcomes.

Bones, Joints & Muscles - Related Articles